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How antibodies alter the cell entry 
pathway of dengue virus particles in 
macrophages
Nilda V. Ayala-Nunez1, Tabitha E. Hoornweg1, Denise P.I. van de Pol1, Klaas A. Sjollema2, 
Jacky Flipse1, Hilde M. van der Schaar3 & Jolanda M. Smit1
Antibody-dependent enhancement of dengue virus (DENV) infection plays an important role in the 
exacerbation of DENV-induced disease. To understand how antibodies influence the fate of DENV 
particles, we explored the cell entry pathway of DENV in the absence and presence of antibodies 
in macrophage-like P388D1 cells. Recent studies unraveled that both mature and immature DENV 
particles contribute to ADE, hence, both particles were studied. We observed that antibody-opsonized 
DENV enters P388D1 cells through a different pathway than non-opsonized DENV. Antibody-mediated 
DENV entry was dependent on FcγRs, pH, Eps15, dynamin, actin, PI3K, Rab5, and Rab7. In the 
absence of antibodies, DENV cell entry was FcγR, PI3K, and Rab5-independent. Live-cell imaging of 
fluorescently-labeled particles revealed that actin-mediated membrane protrusions facilitate virus 
uptake. In fact, actin protrusions were found to actively search and capture antibody-bound virus 
particles distantly located from the cell body, a phenomenon that is not observed in the absence of 
antibodies. Overall, similar results were seen for antibody-opsonized standard and antibody-bound 
immature DENV preparations, indicating that the maturation status of the virus does not control the 
entry pathway. Collectively, our findings suggest that antibodies alter the cell entry pathway of DENV 
and trigger a novel mechanism of initial virus-cell contact.
Dengue is the most common arthropod-borne viral infection in humans. There are four dengue virus serotypes 
(DENV1-4) and these cause around 390 million human infections worldwide each year1. Approximately 500,000 
to 1,000,000 individuals develop severe disease, presenting symptoms like plasma leakage, fluid accumulation, 
respiratory distress, severe bleeding, and organ impairment2. Severe dengue is predominantly seen in infants 
with declining levels of maternal antibodies and in individuals experiencing a heterologous secondary DENV 
infection3. These observations indicate that pre-existing antibodies are a risk factor for severe disease and led to 
the well-known hypothesis of antibody-dependent enhancement (ADE) of DENV infection3. It is hypothesized 
that pre-existing cross-reactive DENV antibodies positively influence the infectious properties of the virus4. As a 
consequence, the total infected cell mass increases and this triggers an imbalanced immune response leading to 
severe disease4. It is, however, not completely understood how the antibodies influence DENV infectivity.
DENV infection is mediated by the envelope (E) glycoprotein and involves three important steps: (1) recep-
tor binding, (2) internalization into the host cell, and (3) membrane fusion5. DENV E was shown to interact 
with a wide range of receptor molecules, including C-type lectins, TIM and TAM receptors, and sulfated gly-
cosaminoglycans (GAGs)6. Upon virus-receptor binding, DENV particles predominantly enter the cell via 
clathrin-mediated endocytosis7–9. The route of entry is however cell- and virus strain-specific10. Membrane 
fusion typically occurs from within late endosomes, where low pH and anionic lipids trigger conformational 
changes in the E glycoprotein to mediate membrane fusion7–9,11. DENV infects a variety of human cells, but cells 
of the monocyte lineage, like macrophages and dendritic cells, are considered the major target cells for DENV 
replication3.
DENV infectivity is controlled by the viral precursor membrane (prM) protein12–15. Within infected cells, prM 
has been shown to stabilize the E protein thereby preventing premature conformational changes within E during 
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transit through the acidic Trans-Golgi network (TGN)12. Prior to the release of progeny virions, prM is cleaved 
into M and a pr peptide. This cleavage reaction is however rather inefficient as DENV-infected cells are known 
to secrete a heterogeneous population of particles, ranging from mature M-containing viruses to fully imma-
ture prM-containing viruses14. Mature virions are considered to represent the infectious form of the virus. Fully 
immature particles, on the other hand, are essentially non-infectious in cells lacking DC-SIGN12,13. Basal low level 
infectivity of prMDENV was seen in cells expressing DC-SIGN16. The threshold of prM cleavage that is required 
for infectivity is currently unknown, although it is clear that not all prM proteins have to be cleaved for infectivity.
Interestingly, antibodies have been observed to stimulate infectivity of both mature and immature virions, 
indicating that all particles contribute to ADE of DENV infection3,17,18. All DENV antibodies identified to date 
can facilitate ADE of DENV infection: enhancement is seen when the antibody concentration falls below the 
threshold required for virus neutralization19. During infection, DENV-antibody complexes are targeted to 
Fc-γ -receptor (Fcγ R) bearing cells and upon interaction of the antibodies with Fcγ R the virion is internalized in 
the cell. The importance of Fcγ Rs in ADE has been confirmed in vitro and in vivo17,20,21. Furthermore, the infec-
tivity of antibody-opsonized immature DENV was found to be dependent on cellular furin activity, suggesting 
that immature virions mature upon virus entry17. An early study suggested that antibody-opsonized virions enter 
the cell via phagocytosis22. This was based on the observation that the internalization rate of antibody-opsonized 
virions resembled the rate of phagocytosis in macrophages22,23. However, no details are known about the exact cell 
entry route of antibody-opsonized DENV in Fcγ R-bearing cells.
In this study, we unraveled the DENV cell entry pathway in the absence and presence of enhancing con-
centrations of antibodies in macrophage-like P388D1 cells. Virus cell entry was analyzed by (i) studying the 
dynamics of viral entry with single-particle tracking, (ii) examining the effect of a variety of endocytic pharma-
cological inhibitors on viral fusion, (iii) imaging – in real time – the interaction of the actin cytoskeleton with 
fluorescently labeled single virus particles, and (iv) exploring the Ab-DENV intracellular pathway by using Rab 
mutants. Furthermore, to address the role of prM on virus cell entry, we used both antibody-opsonized mature 
and immature DENV particles.
Results
Dynamics of antibody-mediated DENV cell entry. Antibody-mediated cell entry of DENV was inves-
tigated by use of human monoclonal antibodies mAb #753 C6 and mAb #3-147, which recognize the E and 
prM proteins respectively18,24. Standard DENV (stdDENV) was produced on C6/36 mosquito cells and imma-
ture DENV (prMDENV) was cultivated on furin-deficient LoVo cells, as described by us before13. LoVo-derived 
DENV contains high levels of prM (on average 94%) in the viral membrane (13, Fig. S1). The particle-to-PFU 
ratio of prMDENV preparations used for microscopy was 7 × 107 (Table S1) and at least 100,000-fold reduced 
compared to that of stdDENV. This is in line with previous studies13,17 and shows that prMDENV is essentially 
non-infectious in BHK21 clone 15 cells.
After the initial characterization of the virus preparations, we determined the enhancing profile of the mAbs 
on murine macrophage-like P388D1 cells. We used P388D1 cells since they express Fcγ RIII (CD16), Fcγ RII 
(CD32), and Fcγ RI (CD64)25,26 and are known to support ADE of DENV27,28. Murine Fcγ Rs are considered to be 
structurally related to human Fcγ Rs29, hence, human antibodies are recognized by P388D1 cells. Prior to infec-
tion, mAb #753 C6 was complexed to stdDENV and mAb #3–147 was incubated with prMDENV, as described 
in the methods section. Maximum enhancement of stdDENV infection was obtained at a mAb concentration 
of 40 and 400 ng/mL (Fig. S2A). In case of mAb #3–147, optimal ADE of prMDENV was reached at 0.1 ng/mL 
(Fig. S2B). In agreement with previous studies13, we found that prMDENV is non-infectious in macrophage cells 
in the absence of antibodies (Fig. S2B).
Next, we performed single virus tracking to investigate if antibodies influence the dynamics of viral entry. 
Single DENV particles were visualized by DiD labeling, as described by us before7. The DiD probe was added to 
purified DENV at a concentration of 2 nmol per 5 × 109 virus particles. At this ratio, a uniformly labeled DENV 
preparation was seen in the absence and presence of antibodies (Fig. S3). Approximately 75% of the DiD spots 
had a fluorescence intensity below 40 arbitrary units (a.u.) (Fig. S3C/D). Only particles with a fluorescence inten-
sity lower than 40 a.u. were selected for further analysis as these likely represent single virions. Membrane fusion 
is detected as a sudden increase in DiD fluorescence intensity due to dilution of the probe into the endosomal 
membrane7. The time point of membrane fusion was defined as the moment when fluorescence at least doubled. 
DiD-labeled virions were either first pre-incubated with the antibody at concentrations that cause optimal ADE 
or directly added to P388D1 cells. Subsequently, single-particle tracking of the DiD-labeled virus was performed 
at a time-lapse of 1 frame per second (37 °C) using epi-fluorescence microscopy. Epi-fluorescence was chosen 
over confocal microscopy to allow a fast imaging speed. Movies were recorded for 40 min. More than 35 movies 
were recorded per condition. Figure 1A gives an example of a complete trajectory of an Ab-stdDENV particle in 
a P388D1 cell. Initially, this particle moves within the cell periphery, and then a rapid movement likely via micro-
tubules (red segment of trajectory in Fig. 1A) is observed prior to membrane fusion. The representative movie of 
this trajectory is uploaded as Movie S1. Only a limited number of complete trajectories were recorded as in most 
movies parts of the trajectory were out of focus due to the thickness of P388D1 cells. Therefore, we were not able 
to quantify the trafficking behavior of DENV cell entry in macrophage-like cells.
In Fig. 1B, snapshots of DiD-labeled particles are shown over time. In these images, fusion is seen at 742, 
393 and 1051 seconds post-addition to the cells for stdDENV, Ab-stdDENV and Ab-prMDENV, respectively. 
Quantitative analysis revealed a considerable delay in the fusion time point of Ab-prMDENV with respect to 
Ab-stdDENV and stdDENV (Fig. 1C). As illustrated in Fig. 1C, 50% of the Ab-prMDENV particles have fused 
within 24 min (gray dashed line). On the other hand, however, 50% fusion of Ab-stdDENV and stdDENV parti-
cles was seen at 10 min and 13 min respectively, indicating that the presence of prM in the membrane drastically 
influences the time to membrane fusion.
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Analyzing DENV cell entry by pharmacological inhibitors. We next evaluated the cell entry pathway 
of DENV in the absence and presence of antibodies by using various inhibitors of known endocytic pathways. The 
concentration of the inhibitors used was based on successful inhibition of entry of known fluorescently labeled 
cargo controls, like transferrin, dextran and cholera toxin B (Fig. S4A-E). Furthermore, the cellular metabolic 
activity – an indicator of cell viability – had to be higher than 75% at the effective concentration, as defined 
by MTT assays (Fig. S4F). The effect of the inhibitor on DENV cell entry was measured by use of a fluores-
cence microscopy-based fusion assay30. The novelty of this approach lies within the fact that the inhibitory effect 
is directly measured at the level of virus entry and membrane fusion, thereby minimizing potential pleotropic 
effects of the drugs. The extent of membrane fusion was determined at 30 min post-addition of the virus to the 
cells as the vast majority of the viruses have fused within this time frame (Fig. 1C). At 30 min post-infection, 
cells were washed and the extent of membrane fusion was determined by measuring the total fluorescent signal 
in 15 randomly selected imaging fields, as described in the methods section. Figure 2A–D shows representative 
images of the fusion assays in P338D1 cells. As expected17, no fusion was seen for prMDENV in the absence of 
antibodies. Furthermore and in line with literature5, no fusion was seen in cells treated with ammonium chlo-
ride (NH4Cl), a compound known to neutralize the pH of intracellular compartments. We also noted an overall 
increase in fluorescence intensity when comparing the images from stdDENV and Ab-stdDENV. Indeed, sub-
sequent quantification of the fluorescence intensity in three independent experiments revealed that membrane 
fusion activity is approximately 3.5-fold increased under conditions of ADE (Fig. S5A). The observed increase 
in membrane fusion activity is mainly caused by an increase in the number of fusion-positive cells (2.3 fold, Fig 
S5B). To address if enhanced fusion is due to increased binding of Ab-DENV complexes to cells we next deter-
mined the number of bound particles by qRT-PCR (Fig. S5C). The results show that the enhanced membrane 
fusion activity as observed under ADE conditions can be largely explained by increased binding and entry of 
DENV-immune complexes to P388D1 cells. At ADE conditions, binding is facilitated through antibody-Fc recep-
tor interactions as both viral infectivity (Fig. S6A) and membrane fusion activity (Fig. 2B,C) is severely impaired 
upon treatment of the cells with anti-Fcγ R CD16/CD32 blocker.
Initially, we investigated the role of clathrin and caveolae in DENV cell entry in the absence and presence of 
antibodies. At first, we tried to use chlorpromazine and pitstop2, two well-known inhibitors of clathrin-mediated 
Figure 1. Kinetics of antibody-opsonized DENV entry in macrophages. Single-particle tracking of DiD-
labeled Ab-stdDENV, Ab-prMDENV and stdDENV was performed in P388D1 cells at 1 frame per second.  
(A) Cell image obtained with DIC optics showing a trajectory of a single DiD-labeled Ab-stdDENV particle. 
The white arterisk represents the membrane fusion site. Scale bar: 2 μ m. (B) Snapshots of a DiD-labeled 
stdDENV, Ab-stdDENV, and Ab-prMDENV particle at different time points post-infection. Membrane fusion 
is observed as a sudden increase in fluorescence intensity. The image was artificially modified to show the 
differences in fluorescence intensity, from low (purple) to high (yellow) intensity. (C) The percentage of fused 
virus particles calculated as a function of time. In total 35 trajectories were analyzed for Ab-stdDENV, 37 for 
Ab-prMDENV, and 36 for stdDENV. The time point of membrane fusion was defined as the moment when the 
DiD intensity doubles.
www.nature.com/scientificreports/
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endocytosis. However, these compounds were quite toxic, and at non-toxic concentrations these compounds 
were unable to sufficiently block transferrin uptake (Fig. S4). Thereafter, we tested a dominant negative mutant 
(DNM) of Eps15 (E95/295), a protein that is described to be present in clathrin-coated pits and is important in 
clathrin-mediated endocytosis31. As seen in Fig. 2E–J, the Eps15-DNM inhibited fusion in all three infection 
conditions, albeit to a different extent. The most extensive inhibition (> 80%) was seen following infection with 
stdDENV in the absence of antibodies (Fig. 2E,H). Mediocre inhibition was seen in case of Ab-stdDENV (~40%) 
and Ab-prMDENV (~45%). Treatment of cells with nystatin, a cholesterol binding agent, leads to a complete 
ablation of morphologically identifiable caveolae32. We observed that nystatin treatment had no influence on std-
DENV, Ab-stdDENV or Ab-prMDENV fusion (Fig. 2H–J), which suggests that entry of DENV with and without 
Abs is caveolae-independent.
Figure 2. Antibody-opsonized DENV entry inhibition by endocytic inhibitors. DiD-labeled DENV 
(opsonized and non-opsonized) was added in situ to P388D1 cells in the presence or absence of the 
indicated inhibitors. After 30 min of infection at 37 °C, the cells were washed and snapshots were taken 
with an oil-immersion 100× objective. (A–D) Representative images upon DiD-DENV infection with and 
without prior treatment of the cells with NH4Cl (50 mM) and FcR blocker are shown. Scale bar: 12.5 μ m. 
Fusion inhibition was calculated by analyzing the total extent of membrane fusion of DiD-labeled virus 
with ImageJ. (E–G) Representative images of a fusion assay performed in P388D1 cells electroporated with 
Eps15-GFP (empty vector D3Δ 2 (control) and DNM (E95/295)). Scale bar: 7 μ m. (H–J) Fusion inhibition  
of Eps15 and multiple biochemical inhibitors. An end concentration of 50 μ M nystatin, 150 μ M dynasore, 
200 μ M iminodyn-22, 15 μ M cytochalasin B, 1 μ M latrunculin, 2 μ M wortmannin, or 30 μ M AS-604850 was 
used. The percentage of fusion inhibition was calculated with respect to the empty vector or non-treated 
control, respectively. The average of at least three independent experiments is shown. Error bars represent SEM.
www.nature.com/scientificreports/
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Thereafter, the role of dynamin and actin was measured. Dynamin, a small GTPase, has a critical role in mem-
brane fission events during clathrin- and caveolae-mediated endocytosis and phagocytosis33,34. Actin is involved 
in numerous endocytic pathways, like clathrin-mediated endocytosis, macropinocytosis, caveolae-mediated 
endocytosis, and phagocytosis35. Though the actin cytoskeleton function is variable between distinct endocytic 
pathways35. Treatment of P388D1 cells with dynasore, a compound that interferes with the GTPase activity of 
dynamin1 and dynamin236, abolished membrane fusion activity and infectivity of DENV irrespective of the 
maturation status and with and without prior opsonization with antibodies (Fig. 2H–J and S6B). Furthermore, 
iminodyn-22, another dynamin inhibitor, reduced the membrane fusion extent of stdDENV with 75% and for 
Ab-stdDENV with 95%. Disruption of actin filaments with cytochalasin B and latrunculin was found to reduce 
fusion of Ab-stdDENV, Ab-prMDENV and stdDENV (Fig. 2H–J). Inhibition of PI3K, a key coordinator in 
actin remodeling, through wortmannin specifically reduced membrane fusion activity of Ab-stdDENV and 
Ab-prMDENV (Fig. 2H–J). The importance of PI3K in Ab-stdDENV cell entry was confirmed by the use of 
AS-604850 (Fig. 2I). Wortmannin and AS-604850 had little to no effect on stdDENV fusion (Fig. 2H). These 
results demonstrate that actin and the regulators of actin remodeling play a critical role during Ab-DENV endo-
cytosis. The different response to PI3K inhibitors is consistent with a distinct DENV cell entry mechanism in the 
presence and absence of antibodies.
Ab-DENV activates extensive ruffling of the cell membrane via FcγRs. The actin cytoskeleton 
has been observed to support different processes related to endocytosis, like the invagination of membrane 
Figure 3. Ab-DENV induction of actin cytoskeleton rearrangement via FcγRs. DiD-labeled virus  
(Ab-stdDENV, Ab-prMDENV and stdDENV) was added to eYFP-Actin-expressing P388D1 cells. The cells 
were kept at 37 °C for live-cell imaging with a spinning disk confocal microscope. Ab-DENV was observed to 
localize to the (A) cell body, (B) membrane ruffles and (C) actin filopodia during entry. Scale bar: 7 μ m.  
(D) Time series of antibody-opsonized DENV induced cell membrane ruffling. The white arrowhead indicates 
the place where the ruffle starts. (E–I) Cell movement was quantified over time upon the indicated treatments. 
(E) Representative images of P388D1 cells under the indicated conditions are shown as the overlays of the cell 
body outlines of a time-lapse of 20 min. (F–I) The Movement ratio (MR) quantifies the extent of movement 
of one cell over a frame sequence. See Fig. S7 for more details on how to calculate it. Based on the MR, the 
movement response was classified as Low (MR < 2), Intermediate (MR = 2–3) or Extensive (MR > 3). For each 
condition, 15 cells were used for analysis. The gray area indicates the intermediate response. The proportion of 
cells showing Low, Intermediate, and Extensive response is indicated at the right corner of (E).
www.nature.com/scientificreports/
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segments into the cytoplasm, elongation of invaginations, and protrusions in the form of filopodia and ruffles35,37. 
In order to study how DENV particles interact with the actin cytoskeleton, we performed live-cell imaging in 
eYFP-Actin expressing P388D1 cells. Interestingly, dramatic changes in cell morphology and actin redistribution 
were observed upon infection with DiD-labeled Ab-stdDENV and Ab-prMDENV (Fig. 3). Ab-stdDENV and 
Ab-prMDENV particles were not only seen at the cell body (Fig. 3A), but also associated with membrane ruffles 
(Fig. 3B) and filopodia-like structures (Fig. 3C). Ruffles were observed across the cell membrane as sheet-like pro-
trusive structures with a heterogeneous morphology (Fig. 3D). The extensive actin-driven membrane ruffling of 
the cell is illustrated by Movies S2 and S3. In the absence of any added stimuli (negative control), the eYFP-Actin 
expressing macrophages are constitutively active (as reported by Flannagan et al.38), but do not show widespread 
ruffling of the membrane (Movie S4). Ruffling induced by Ab-stdDENV and Ab-prMDENV is initiated at 3 to 
5 minutes post-infection (mpi) (Movies S5 and S6). Movie S5 shows eYFP-Actin expressing cells during the first 
4.5 minutes following infection with Ab-stdDENV. DiD-labeled particles are visible, but not yet bound to the 
cell membrane. A constitutive movement of the cell body can be seen. Movie S6 shows the same group of cells at 
5 mpi. A widespread and highly active ruffling of the cells is evident.
But what is triggering membrane ruffling? Is it the immune complex, the virus or the antibody? To address 
this issue, we first developed an ImageJ-based method to quantify the extent of cell ruffling in one cell. With 
this method, we calculated the “Movement ratio” (MR) by dividing the “total area” covered by a moving cell for 
the whole sequence, with respect to the smallest surface area occupied by the same cell in the same time series 
(explained in detail in Fig. S7). Based on the resulting Movement ratio, cells were classified in three groups: Low 
(MR < 2), Intermediate (MR = 2–3), and Extensive (MR > 3). To visually illustrate the results, the projections of 
the cell body outlines of a time-lapse of 20 min are shown in Fig. 3E. No differences were observed between the 
ruffling response activated by Ab-stdDENV (Movie S2) and Ab-prMDENV (Movie S3). Extensive membrane 
ruffling is observed in approximately 50% of the cells infected with Ab-stdDENV (47%) and Ab-prMDENV 
(53%) (Fig. 3E,F). Ruffling is also observed in cells infected with stdDENV and prMDENV in the absence of anti-
bodies, but this ruffling is less extensive compared to Ab-stdDENV and Ab-prMDENV (Fig. 3E,F). Cytochalasin 
B prevented membrane ruffling in all conditions (MR < 2). The addition of soluble anti-E and anti-prM anti-
bodies to the cells also induced membrane ruffling, albeit to a somewhat lower extent than antibody-opsonized 
DENV (Fig. 3G). Similar results were found upon addition of dengue patient immune serum and an non-DENV 
murine IgG antibody. These results prompted us to further study the role of antibodies in ruffling induction of 
the cell membrane. The use of a Fcγ R blocker (anti-CD16/CD32) prevented ruffling induced by Ab-stdDENV, 
Ab-prMDENV and by soluble anti-E mAbs (Fig. 3H). In addition, we observed that Fab fragments with and 
without prior opsonization to stdDENV and prMDENV particles do not induce extensive ruffling (Fig. 3I). 
Taken together, these results indicate that activation of membrane ruffling in macrophages by Ab-stdDENV 
and Ab-prMDENV is likely triggered through the interaction of the antibodies with Fcγ Rs expressed at the cell 
surface.
Antibody-mediated DENV entry is not mediated by macropinocytosis. Ruffling, the involvement 
of actin, and the role of PI3K is suggestive for Ab-stdDENV cell entry via macropinocytosis. Macropinocytosis 
has been suggested as an alternative DENV cell entry pathway in HepG2 cells and was found to be important 
for several other viruses9,39. Macropinocytosis is an actin-dependent process characterized by the formation of 
macropinosomes, which are structures derived from the eukaryotic plasma membranes ranging in size from 
Figure 4. Role of antibody-induced macropinocytosis in virus internalization. (A) P388D1 cells were 
treated with EIPA (25 μ M) for 1 h at 37 °C. Cells were infected with DiD-labeled stdDENV and Ab-stdDENV 
and analyzed as in Fig. 2. (B) Fluid phase uptake of Dextran-TxRd upon addition of stdDENV, Ab-stdDENV 
or mAb # 753 C6. PMA (60 ng/ml) was added as a positive control. All treatments were added 15 min before 
addition of Dextran-TxRd. Uptake of Dextran (0.4 mg/ml) was allowed for 30 min at 37 °C. The average of five 
independent experiments is shown. Error bars represent SEM.
www.nature.com/scientificreports/
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0.2 to 10 μ m that are used to engulf extracellular fluid for cellular uptake40. The effect of amiloride derivative 
EIPA on virus cell entry is often used to study the importance of macropinocytosis. EIPA has been described to 
inhibit Na+/H+ exchanger (NHE) activity thereby modulating Rho GTPases and interfering with macropino-
some formation41. EIPA inhibited membrane fusion activity of Ab-stdDENV and stdDENV albeit with a rather 
low efficiency (Fig. 4A). The weak inhibitory effect of EIPA combined with the notion that NHEs can also be 
found in membranes of other intracellular vesicles42, thereby potentially interfering with other pH-dependent 
pathways, makes it difficult to interpret this data. Therefore, we next investigated another hallmark of macropi-
nocytosis: increased fluid uptake. Figure 4B shows that there is no increased fluid uptake during infection with 
stdDENV, Ab-stdDENV and upon the addition of soluble antibody, whereas a marked increase in fluid uptake 
was seen upon addition of the known macropinocytosis inducer PMA. Furthermore, upon close examination of 
the recorded movies, only very few ruffles were seen that close to form vesicles and only a minor fraction of these 
vesicles contained visible Ab-stdDENV (4 out of 50) or Ab-prMDENV (2 out of 50). Taken together, although we 
noticed extensive actin-mediated ruffling at the plasma membrane and sometimes closure of vesicles, macropi-
nocytosis does not appear to have an important role in DENV cell entry in macrophages.
Interaction of Ab-opsonized DENV with actin cell-surface protrusions. To better understand how 
virus particles interact with the plasma membrane and to decipher the role of actin herein, we further ana-
lyzed the recorded movies. We observed that many virus particles were indeed internalized through localized 
cell-surface actin protrusions (Fig. 5). These were not considered as part of the ruffling response described in the 
previous section, since ruffling was observed as a general response of the complete cell body and these protru-
sions represent localized reactions to a viral particle.
We observed two types of localized actin-mediated uptake of Ab-DENV. Type 1 implies uptake through actin 
protrusions that are formed upon direct virus-cell contact (Fig. 5A). In case of Type 2, actin protrusions were 
generated towards viral particles located away from the cell body. Once the actin-mediated structure reached 
the virus particle, the protrusion retracts and pulls back the virion to the cell membrane (Fig. 5C and Movie S7).
To evaluate the efficiency of these processes we quantified the number of events by visual examination. Type 
1 and Type 2 virus-cell interactions were counted in 73 cells per virus condition and classified as successful or 
unsuccessful, based on the ability of the actin protrusion to mediate viral uptake. In total, 29 virus-cell interactions 
were recorded for stdDENV, 60 virus-cell interactions for Ab-stdDENV and 31 for Ab-prMDENV. Representative 
examples are shown in Fig. 5A–D. Figure 5A shows a successful Type I uptake. The antibody-opsonized 
DiD-labeled particle is bound to the plasma membrane. At 2.6 mpi, an actin protrusion starts to surround the 
virus particle and subsequently captures it. Figure 5B shows an unsuccessful Type 1 uptake. This particle is sur-
rounded by actin protrusions but did not end up inside a cellular compartment. A successful Type 2 uptake 
is illustrated in Fig. 5C. Initially, an antibody-opsonized virus is seen approximately 5 μ m away from the cell 
body. Then, an actin-rich structure protrudes and elongates in the direction of the virus particle. This protrusion 
reaches and binds to the viral particle, and pulls it back to the cell body. The complete process lasts 54 seconds. 
This is also visible in Movie S7. Figure 5D presents an unsuccessful Type 2 uptake. Here, actin protrusions are 
directed towards the virion but fail to pull it back. Since we sometimes observed repeated attempts of the cell to 
capture the same particle (Movie S8), we believe that Type 2 movement represents a specific direct process to cap-
ture virus particles from the extracellular environment. In all conditions, Type 1 appears to be more efficient than 
Type 2 (Fig. 5E–G). The frequency of successful Type 1 uptake is similar for Ab-stdDENV, Ab-prMDENV and 
stdDENV (Fig. 5E–G). Interestingly, Type 2 interactions were hardly detected following stdDENV infection in 
the absence of antibodies. Moreover, the Type 2 interactions that were seen upon stdDENV infection were never 
successful. Successful Type 2 uptake was however seen in 8 out of 36 (22%) events for Ab-stDENV and 4 out of 11 
(36%) for Ab-prMDENV (Fig. 5E,F).
As observed in Fig. 5C, Type 2 uptake is directed specifically against a single virus particle that is not moving 
and not associated with the plasma membrane or any other visible actin structure. But how is the cell able to sense 
the presence and position of the virus without having contact with it? Or is the membrane surface area of the cells 
wider than seen by eYFP-Actin? To address this issue, we stained the membranes of eYFP-Actin expressing cells 
with the lipophilic probe DiD and used high resolution differential interference contrast (DIC) microscopy to 
evaluate the membrane surface area of the cells. The DiD signal completely overlaps with eYFP-Actin, indicating 
that all cellular structures are detected with eYFP-Actin (Fig. S8). At this moment we do not know how cells sense 
the virions. Importantly, though, successful Type 2 interactions were only observed in case of Ab-stdDENV and 
Ab-prMDENV and therefore this sensing mechanism is linked to the presence of antibodies (Fig. 5G).
Endocytic trafficking of antibody-opsonized DENV. After uptake and internalization, most viruses 
traffic through intracellular vesicles until a compartment is reached where membrane fusion occurs (refer to43 
for an extensive review). The intracellular compartments hijacked by viruses can be endosomes, phagosomes or 
pinosomes, all of which have been described to undergo acidification and a maturation process that involves the 
gain and loss of early/late markers before fusion with lysosomes39,43. Since trafficking of the different intracellular 
compartments is controlled by Rab GTPases44, we used a set of fluorescently-labeled Rab dominant-negative 
mutants (DNM) to analyze which of these GTPases is required for viral transport. Fluorescently-labeled dextran 
was used as a control to evaluate the activity of the DNMs. Figure S9 shows that the overexpression of Rab5 
and Rab7 DNMs inhibited uptake of the fluorescently-labeled dextran. DENV membrane fusion activity was 
reduced in cells transfected with DNM of Rab7 for all experimental conditions (Fig. 6A–C), particularly in the 
case of stdDENV in the absence of antibodies (88% of inhibition with respect to the WT Rab7). Interestingly, 
Rab5 was important for Ab-DENV fusion (black bars, Fig. 6D–F), but not for stdDENV. Unfortunately, though, 
these results could not be confirmed by flow cytometry given the low transfection and infection efficiency in 
macrophages.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:28768 | DOI: 10.1038/srep28768
Discussion
The study presented here aimed to understand how DENV enters macrophages in the absence and presence 
of antibodies. DENV entry in P388D1 cells was found to be Eps15, dynamin, actin, pH and Rab7-dependent, 
but Fcγ R, caveolae, PI3K, macropinosome and Rab5-independent. Antibody-mediated DENV entry, on the 
other hand was found to be Fcγ R, dynamin, actin, PI3K, pH, Rab5 and Rab7-dependent, partially dependent 
on Eps15, and caveolae- and macropinosome-independent. Thus, the route of DENV cell entry in the absence 
and presence of antibodies can be distinguished on the basis of Fcγ R, PI3K and Rab5. In addition, a novel 
mechanism of virus capture was detected during antibody-mediated uptake of DENV particles in P388D1 
Figure 5. Ab-DENV uptake is mediated by actin protrusions. The experimental set-up is similar as described 
in the legend to Fig. 3. (A–D) Representative montages of alternating time-lapse exposures of DiD-DENV and 
eYFP-Actin during entry. (A,B) Type 1 virus uptake. (C,D) Type 2 virus uptake. DiD-virus is shown in red. 
eYFP-Actin expressing cells are shown in green. White arrowheads point out single viral particles associated 
with actin structures. (E–G) Frequency of Type 1 and type 2 uptake in a total of 60 events.
www.nature.com/scientificreports/
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Figure 6. Effect of Rab5 and Rab7 dominant-negative mutants in fusion of Ab-DENV. DiD-labeled DENV 
(with and without antibodies) was added in situ to P388D1 cells electroporated with the indicated plasmids. 
(A–C) Representative examples of membrane fusion. Membrane fusion of DiD-labeled virus is observed as 
highly fluorescent red puncta in the WT and DNM electroporated cells. All plasmids have GFP as a reporter 
gene. Scale bar: 7 μ m. (D–F) Quantification of the effect of the DNM proteins on viral fusion. For analysis, 85 
cells positive for the expression of the plasmids were used. The percentage of inhibition was calculated with 
respect to the WT plasmid control.
www.nature.com/scientificreports/
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cells. Furthermore, except for the time to membrane fusion, there were no evident differences between the 
entry profile of Ab-prMDENV and Ab-stdDENV particles.
Dengue virus cell entry in the absence of antibodies does not fit with a classical textbook view of one endocytic 
process. The importance of Eps15 and dynamin is suggestive for entry via clathrin-mediated endocytosis although 
also clathrin-independent pathways have been described to use dynamin and Eps1531,45. The actin cytoskeleton 
is important in numerous endocytic and phagocytic processes, but the function of actin within these processes is 
different37. In clathrin-mediated endocytosis, actin has been described to support the process of invagination of 
the membrane and can help with the elongation and scission of the new vesicle37. We observed that actin forms 
active membrane protrusions that engulf the particles (Type 1), a phenomenon that has been linked to phagocytic 
processes46,47. Entry through phagocytosis seems unlikely, however, since PI3K is not required in DENV cell entry 
and this molecule is generally believed to be important for phagosomal maturation46,48,49. Therefore, we propose 
that DENV entry in macrophages is via a novel mechanism involving elements of clathrin-mediated endocytosis 
and phagocytosis. The ability of a virus to use non-classical entry pathways displaying features of multiple estab-
lished endocytosis pathways has been described before50–52. Furthermore, enhanced membrane fusion was seen 
in Rab5-DNM expressing cells whereas a marked inhibition was noticed in Rab7-DNM cells. This suggests that 
DENV particles bypass Rab5 organelles and are immediately delivered to Rab7 compartments where membrane 
fusion occurs. This is in contrast to our earlier results in BS-C-1 cells7 and indicates that the endocytic behavior 
is cell type-specific. Although more experiments are required to confirm this finding, similar results have been 
described for lymphocytic choriomeningitis virus51. The authors suggested that this atypical transport behavior 
may serve to internalize plasma membrane molecules and bound ligands that need to avoid recycling regulated by 
Rab5 early endosomes51. The conclusion that DENV fuses from within Rab7 compartments is in agreement with 
our earlier data7 and is in line with the described lipid dependence for DENV fusion11.
The internalization profile of antibody-opsonized DENV is similar to stdDENV entry except for the role of 
Fcγ Rs and PI3K. This implies that antibodies influence the fate of DENV cell entry. Fcγ Rs46, dynamin53, active 
formation of actin protrusions46, and PI3K54 have been prior linked to phagocytosis. Furthermore, Type I uptake 
looks like a phagocytic cup. Therefore, we propose that cell entry of antibody-opsonized DENV occurs via 
phagocytosis, which is in line with the conclusions of Halstead et al.22. Inhibition of Eps15 partially inhibited 
antibody-opsonized DENV entry in macrophages. This can be explained by phagocytosis, as different elements 
of the clathrin machinery, like AP-2, have been located in the outer layer of phagosomes and play a role in pha-
gosomal maturation55. Phagocytosis-like entry may seem unexpected given the relatively small size of Ab-DENV 
complexes. Indeed, it is generally believed that phagocytosis is meant for uptake of particles larger than 0.5 μ m46. 
Yet, phagocytosis-like pathways have been described for viruses smaller than 0.5 μ m, like Adenovirus type 2 
(90–100 nm)56 and HSV-1 (200 nm)57. Hence, the size of the particles is not the only determinant needed to trig-
ger phagocytosis. Upon phagocytosis, the antibody-opsonized particles traffic through Rab5 and Rab7 organelles 
and both early and late phagosomes are required for entry and membrane fusion in P388D1 macrophages. Given 
the pH and lipid requirements for fusion, we anticipate that the virus predominantly fuses from within late pha-
gosomal compartments.
A surprising novel finding was Type 2 uptake of antibody-opsonized stdDENV and prMDENV. To our 
knowledge, this is the first study that describes the possibility of a cell to actively search and capture a virus par-
ticle from the environment. But how is the cell able to detect virus particles located away from its main body? 
A possible explanation is chemotaxis. Antibodies are known to associate and dissociate from their antigen over 
time. It is tempting to speculate that the dissociated antibodies leak away from the complex and serve as a chemo-
tactic stimulus that macrophages can sense. Indeed, successful Type 2 uptake was not observed with stdDENV in 
the absence of antibodies. Thus, antibodies not only flag the virus as a foreign antigen that needs to be degraded, 
they may also induce an active capturing mechanism in macrophage cells. In this sense, Type 2 is a remarkable 
example of how viruses could utilize pathogen-sensing functions of macrophages.
Extensive membrane ruffling was observed upon DENV infection in presence of antibodies. Most of these 
ruffles did not close to form macropinosomes and no enhanced fluid uptake was seen. This shows that exten-
sive membrane ruffling is not necessarily linked to the process of macropinocytosis. Indeed, membrane ruffling 
has also been linked to receptor internalization, preparation of cell motility, and cell migration58. Future studies 
should reveal whether the observed membrane ruffling, which is triggered by antibody-Fc receptor interaction, 
indeed reflects the initiation of cell motility and/or migration.
We observed that the fusion time point of DiD-labeled Ab-prMDENV particles is approximately two 
times delayed compared to Ab-stdDENV. Yet, there were no clear differences observed in the entry profile, 
indicating that the maturation status of the virus influences the time to membrane fusion but not the entry 
pathway itself. Previous studies showed that immature DENV has to undergo a furin-dependent maturation 
process prior to membrane fusion17. It is known that progeny virions release the pr peptide upon secretion of 
the particle to the extracellular pH neutral milieu. During infection, it is hypothesized that the lower pH of 
late phagosomal compartments – when compared to the luminal pH of vesicles within the Golgi apparatus – is 
sufficient to release the pr peptide from the virion59. Hence, we postulate that the additional time required to 
initiate membrane fusion reflects the processes involved in virion maturation rather than hijacking a distinct 
route of cell entry.
DENV-immune complexes bound more efficiently to P388D1 cells than DENV particles in the absence of 
antibodies. In primary macrophages, however, no increase in virus cell binding and entry was observed under 
ADE conditions (unpublished results/accompanying manuscript). These contradicting results may reflect differ-
ences in virus receptor and Fc receptor expression levels60,61. Indeed, in the absence of antibodies, the number 
of bound particles was much lower in P388D1 cells than in primary macrophages. On the other hand, however, 
comparable numbers of bound particles were seen in P388D1 cells and primary macrophages under ADE con-
ditions. This suggests that P388D1 cells express lower levels of virus receptors than primary macrophages. The 
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relative low binding efficiency of DENV to P388D1 cells might also explain why a more robust ADE effect is seen 
in these cells. Indeed, previous studies on immature dendritic cells revealed that the expression level of the virus 
receptor DC-SIGN is inversely correlated with ADE60.
It is important to mention that the antibody/FcR-mediated entry pathway by itself does not explain ADE. 
Under neutralizing conditions, virions will also enter macrophages via an antibody-mediated pathway62. Indeed, 
Fcγ Rs have been shown to be important in antibody-mediated neutralization as well as antibody-mediated 
enhancement of infection3,62,63. Hence, it is likely that a similar entry pathway is used under neutralizing and 
enhancing conditions. What then determines the enhancing or neutralizing capacity of the antibody? We and 
others have suggested that ADE is controlled at the level of membrane fusion61,63. Fcγ RIIBFusion and thus ADE 
may occur when antibodies dissociate from the virion during entry or bind with low occupancy thereby allowing 
unoccupied E proteins to initiate fusion. At very high concentrations of neutralizing antibodies, DENV-Ab aggre-
gates are formed and inhibit phagocytosis through crosslinking of Fcγ RIIB62, which suggests that depending on 
the antibody concentration of neutralizing antibodies distinct mechanisms can occur.
In conclusion, our results provide evidence for a novel antibody-mediated mechanism meant to regulate the 
uptake and internalization of DENV particles in macrophages. The overall entry pattern of Ab-stdDENV and 
Ab-prMDENV was similar, indicating that the antibody dictates the route of entry and not the virion. This data 
not only elucidates how antibodies alter the cell entry pathway of DENV particles in macrophages, but also shows 
that Ab-virus complexes can take advantage of an active pathogen-sensing mechanism of macrophages. It would 
be interesting to establish whether the intervention of these entry pathways may be useful in the design of antivi-
ral drugs that can be used in dengue severe disease.
Methods
Cells and viruses. Murine macrophage P388D1 cells were kindly provided by Dr. Michael Diamond 
(Washington University in St. Louis, USA), they are also available through ATCC (No. CCL-46). P388D1 cells were 
maintained in DMEM (PAA) supplemented with 10% FBS, penicillin (100 U/mL), streptomycin (100 μ g/mL), 
sodium bicarbonate (Invitrogen, 7.5% solution) and 1.0 mM sodium pyruvate (Gibco). Baby hamster kidney 
clone 15 (BHK-15) cells (gift from Dr. Richard Kuhn, Purdue University, USA) were cultured in 1x high glucose, 
L-glutamine-enriched DMEM with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μ g/mL). Aedes albop-
ictus C6/36 cells (also obtained from Dr. Richard Kuhn, ATCC No. CCL-1660) were maintained in MEM (Gibco) 
supplemented with 10% FBS, 25 mM HEPES, 7.5% sodium bicarbonate, penicillin (100 U/mL), streptomycin 
(100 μ g/mL), 200 mM glutamine and 100 μ M nonessential amino acids at 30 °C. Human adenocarcinoma (LoVo) 
cells (obtained from ATCC No. CCL-229) were cultured in Ham’s F-12 medium (Gibco) supplemented with 20% 
FBS, penicillin (100 U/mL), and streptomycin (100 μ g/mL). All cells except for C6/36 were maintained at 37 °C 
and 5% CO2.
DENV2 strain 16681 was kindly provided by Dr. Claire Huang (Center for Disease Control and Prevention, USA). 
It was propagated in C6/36 cells as described before and called stdDENV13. prMDENV particles were produced in 
LoVo cells, as described previously13. Viral infectivity was determined by plaque assay on BHK-21 clone 15 cells 
(plaque forming units, PFU)13. The absolute number of virus particles in solution was determined by quantitative 
PCR (qPCR), which detects the number of genome-containing particles (GCPs)17. Virus infection was performed 
on the basis of multiplicity of genome-containing particles per cell (MOG).
Antibodies. Human anti-E (mAb #753 C6) and anti-prM (mAb #3–147) were a generous gift from prof. 
G. Screaton (Imperial College, London, UK)18,24. Purified anti-Mouse CD16/CD32 (Mouse BD Fc Block) was 
obtained from BD Biosciences. Convalescent human dengue immune serum (28 days following DENV2 infec-
tion) was generously provided by Dr. G. Comach (Biomed-UC, Lardidev, Maracay, Venezuela) and Dr. T. Kochel 
(U.S. Naval Medical Research Center Detachment, Lima, Peru). Mouse IgG2A non-DENV Control (anti-KLH) 
was acquired from R&D Systems. Fab fragments were made from the monoclonal murine anti-E antibody 4G2 
(Millipore) by use of the Pierce™ Fab Micro Preparation Kit.
Drugs and reagents. Endocytotic inhibitors such as chlorpromazine, wortmannin, nystatin, dynasore, 
AS-604850, cytochalasin B, latrunculin and EIPA were purchased from Sigma Aldrich. Pitstop2 and iminodyn-22 
was purchased from Abcam. Ammonium chloride (NH4Cl) was obtained from Merck. A furin-specific inhib-
itor, decanoyl-L-arginyl-L-valyl-L-lysyl-L-arg inyl-chloromethylketone (decRRVKR-CMK), was obtained from 
Calbiochem. The fluorescently labeled endocytic cargos Cholera toxin B-FITC (CtxB-FITC), Dextran-FITC, 
Dextran-TxRd, and LysotrackerGreen were purchased from Life Technologies.
Plasmids. The GFP-tagged dominant-negative Eps15 mutant E95/295 and its empty vector D3Δ 2 were 
kindly provided by Dr. A. Benmerah and Dr. A. Dautry-Varsat (Institute Pasteur, Paris, France). The eYFP-Actin 
construct (human β -actin in a pCDNA3.1 vector) was obtained from Dr. Ben Giepmans (UMCG, Groningen, 
The Netherlands). The Rab5-S34N-GFP dominant negative mutant (DNM) and Rab5-wt-GFP plasmids 
were generously provided by Dr. P. van der Sluijs (University Medical Center, Utrecht, The Netherlands). The 
Rab7-T22N-GFP DNM and Rab7-wt-GFP plasmids were obtained from Gary R. Whittaker (Cornell University 
College of Veterinary Medicine, NY, USA).
ADE assay. For virus-antibody complex formation, virus particles (MOG 1000 of std as well as prMDENV) 
were incubated for 30 min at 37 °C in presence of serial 10-fold dilutions of antibodies in cell culture medium 
containing 2% FBS. The virus-antibody complexes were then added to 2 × 105 P388D1 cells/well, and incubated at 
37 °C with 5% CO2. At 43 hours post-infection (hpi), the supernatant was collected and virus particle production 
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was measured with a plaque assay. As controls, an FcR blocker (anti-mouse CD16/CD32) and dynasore were 
used. The cells were pretreated with the FcR blocker (1 μ g per 1 × 106 cells) for 10 min at 4 °C before infection, 
whereas dynasore (150 μ M) was added to the cells 1.5 h before infection.
DiD-labeling of DENV. The lipophilic fluorescent probe 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine, 
4-chlorobenzenesulfonate salt (DiD) (Molecular Probes) was used to label the viral membrane of DENV virus 
particles, as previously described30. When incorporated in the viral membrane at a relatively high surface den-
sity, the emitted fluorescence level is largely quenched, but single DiD-labeled virus particles can still be clearly 
detected. Membrane fusion is detected as an increase in fluorescence intensity due to dilution of the probe into 
the target membrane.
Microscopic fusion assay. Fusion assays were carried out for DENV in the absence and presence of anti-
bodies. In these assays, the antibody concentration (resp. 400 ng/mL for mAb #753 C6 and 1 ng/mL for mAb 
# 3–147) that showed maximal enhancement in the infectivity assays was used. Virus antibody opsonization 
was done as described for the ADE assay. DENV and mAb-DENV complexes were added to P388D1 cells and 
incubated for 30 min at 37 °C with 5% CO2. Then, the cells were washed three times with serum-free, phenol 
red-free MEM and subjected to microscopic analysis in a Leica Biosystems 6000B instrument. In case of drug 
inhibitor studies, the cells were prior treated with the drug of interest for the indicated times: Pitstop2 for 10 min; 
Iminodyn-22 and AS-604850 for 30 min; NH4Cl and EIPA for 1 h; chlorpromazine, nystatin, dynasore, cytocha-
lasin B, lantruculin and wortmannin for 1.5 h at 37 °C. An end concentration of 50 mM NH4Cl, 25 μ M Pitstop2, 
15 μ M chlorpromazine, 50 μ M nystatin, 150 μ M dynasore, 200 μ M Iminodyn-22, 15 μ M cytochalasin B, 1 μ M 
latrunculin, 2 μ M wortmannin, 30 μ M AS-604850 or 25 μ M EIPA was used. All drug dilutions were prepared in 
serum-free phenol red-free MEM (Gibco) containing 1% glucose and used at non-toxic concentrations. Infection 
was done in the presence of the compound. Differential interference contrast (DIC) settings were used to ran-
domly select fields. A total of 15 randomly selected fields were taken using both DIC and DiD channels. For the 
excitation of DiD a 635-nm helium–neon laser was used. The acquired images were processed and analyzed with 
ImageJ using an in-house macro. The extent of membrane fusion was quantified by measuring the total fluores-
cent signal per field of view with the “Particle analyzer” plugin of ImageJ. The percentage of fusion inhibition was 
calculated with respect to the non-treated positive control.
Single-particle tracking of DiD-DENV. The tracking experiments were performed as previously 
described30. Briefly, P388D1 cells were seeded in 8-wells Lab-Tek II Chambered Coverglass two days before 
infection. Prior to the experiment, cells were washed three times with phenol red-free MEM and warm phenol 
red-free MEM containing 1% glucose was added. DiD-labeled DENV (opsonized or non-opsonized std- and 
prMDENV) was added to P388D1 cells at 37 °C and kept at the same temperature throughout the tracking exper-
iment. DiD-labeled DENV was detected with a 635-nm helium-neon laser. Image series of the fluorescent emis-
sion were recorded with a charge-coupled-device camera at 1 frame per s using an epi-fluorescence set-up. Before 
and after fluorescence imaging, the localization of the nucleus and plasma membrane of the cell was determined 
by use of DIC optics. The acquired images were processed and analyzed with ImageJ (NIH) and Imaris x64 7.6.1 
(Bitplane Scientific Software). Only those virus particles in which the initial fluorescence intensity was below 
40 a.u. and that showed more than a two-fold increase in fluorescence intensity upon membrane fusion were used 
for single-particle tracking analysis. Trajectories were generated by pairing peaks in each frame to previously 
established trajectories according to proximity and similarity in intensity.
Electroporation of P388D1 cells. A suspension containing 3× l06 cells (in antibiotic-free DMEM con-
taining 10% FBS) and 10 μ g of DNA plasmid were placed in a 0.4 cm electroporation cuvette (Bio-Rad). The 
electroporation was performed at room temperature, 950 μ F and 250 V. Afterwards, the cuvette was kept at room 
temperature for 4 min. The cells were then resuspended and seeded in an 8-wells Lab-Tek using antibiotic-free 
10% FBS DMEM. The media was refreshed one day after electroporation. The cells were used for imaging at two 
and three days post-electroporation.
Live-cell imaging in eYFP-Actin expressing cells. P388D1 cells were transfected with the eYFP-Actin 
construct (10 μ g of DNA per 3 × 106 cells) by electroporation and seeded in an 8-wells Lab-Tek II Chambered 
Coverglass. At 2 days post-electroporation, the cells were washed with serum-free phenol red-free MEM and 
fresh serum-free phenol red-free 1% glucose MEM was added to the well. Then, DiD-labeled virus (stdDENV 
or prMDENV) with and without prior antibody opsonization was added in situ in the presence or absence of 
the indicated treatments. The virus used for live-cell imaging was UV-inactivated for 1 h. UV-treatment did not 
interfere with membrane fusion activity as assessed by the microscopic membrane fusion assay. The eYFP-Actin 
expressing living P388D1 cells were then imaged with a Solamere Spinning Disk Confocal Live Cell Imaging 
system (Solamere Technology Group). This system is based on a confocal Leica DM IRE2 Inverted microscope 
(Leica Microsystems) equipped with a temperature and CO2 controlled box (Live Imaging Services). YFP and 
DiD fluorescence were recorded with a Stanford Photonics XR/Mega-10 ICCD camera (Stanford Photonics) 
using argon (488 nm) and krypton (647 nm) lasers as light sources, respectively. Time-lapse acquisition was done 
at 1 image every 4.5 seconds with a 63× objective. Only one focal plane was imaged as analysis in Z-axis drasti-
cally reduced the imaging speed. The acquired images were processed and analyzed with Imaris × 64 7.6.1 and 
ImageJ.
Fluid phase uptake. P388D1 cells were seeded in 8-wells Lab-Tek II Chambered Coverglass two days before 
infection. Cells were washed once with phenol red-free MEM and warm phenol red-free MEM containing 1% 
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glucose and either PMA (60 ng/ml; Sigma), stdDENV, Ab-stdDENV or mAb # 753 C6 was added. Cells were incu-
bated for 15 min at 37 °C and subsequently Dextran-TxRd (final concentration: 0.4 mg/ml) was added. Uptake of 
Dextran was allowed for 30 min at 37 °C, after which cells were washed 3× with warm phenol red-free MEM and 
fixated with 4% PFA. Differential interference contrast (DIC) settings were used to randomly select fields. A total 
of 15 randomly selected fields were taken using both DIC and TexasRed channels. The percentage of fluid phase 
uptake was calculated with respect to the non-treated positive control.
Dominant-negative mutant assays. DiD-labeled DENV was added in situ to P388D1 cells electroporated 
beforehand with the Eps15-GFP (DNM E95/295 and its empty vector D3Δ 2) Rab5-GFP (DNM S34N and WT) 
and Rab7-GFP (T22N DNM and WT) plasmids. A fusion assay was performed as described in previous sections. 
To assess the effect of the DNM on membrane fusion of the virus, the extent of membrane fusion was quantified 
in 85–100 cells positive for the expression of the plasmid (GFP+ ) as described in previous sections. The percent-
age of inhibition of fusion of the DNM was calculated with respect to the WT plasmid control.
Fluorescently labeled cargo controls for biochemical inhibitors and DNM. To confirm the inhib-
itory activity of the chemical inhibitors, different fluorescently labeled cargo controls were used. The activity of 
nystatin was confirmed by incubation of cells with CtxB-FITC for 30 min at 37 °C. Cells treated with dynasore, 
cytochalasin B, latrunculin, wortmannin, AS-604850 and EIPA were incubated with either Dextran-FITC or 
Dextran-TxRd for 30 min at 37 °C to assess the inhibitory effect. Transferrin-AF633 (15 min at 37 °C) was used 
as a cargo control for chlorpromazine, pitstop2 and Iminodyn-22. To define the effect of ammonium chloride on 
the pH of acidic intracellular vesicles, P388D1 cells were stained with LysotrackerGreen for 15 min at 37 °C, then 
washed twice with serum-free phenol red-free MEM. Visualization was done by use of an epi-fluorescence Leica 
Biosystems 6000B microscope.
The activity of the Rab5 and Rab7 DNM plasmids was confirmed with the use of Dextran-TxRd. P388D1 cells 
were electroporated with the Rab5 or Rab7 WT and DNM plasmids. Two days post-electroporation, the cells were 
treated with Dextran-TxRd (0.03 mg/mL) for 30 min at 37 °C, washed and then imaged to assess Dextran uptake 
or co-localization. Rab5-electroporated cells were visualized with an epi-fluorescence Leica Biosystems 6000B 
microscope. To assess the effect of the Rab5-DNM on uptake of Dextran, 50 cells positive for the expression of 
the plasmid (GFP+ ) were selected and scored as positive or negative for uptake. The percentage of inhibition of 
uptake of the DNM was calculated with respect to the WT plasmid control. On the other hand, since expression 
of the DNM form of Rab7 blocks the exit of cargo molecules from early to late compartments64, the activity of the 
Rab7-DNM was defined by quantifying co-localization of Dextran molecules and Rab7-GFP+ compartments in 
both Rab7 DMN and wt expressing cells. To this end, the cells were fixed with PFA 4% and imaged with a Leica 
SP8 Confocal microscope. Fifty Dextran molecules were assessed per condition.
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